What is Corti?
Corti is a pioneering health-tech company based in Denmark, specializing in artificial intelligence-driven software solutions for healthcare professionals. Its platform actively listens during patient consultations, automating note-taking, searching medical databases, and cross-referencing symptoms with a vast repository of historical cases. This advanced AI aims to optimize patient treatment by providing real-time support and insights to clinicians, positioning Corti as a global leader in applied AI within the healthcare sector.
How much funding has Corti raised?
Corti has raised a total of $92M across 3 funding rounds:
Angel/Seed
$5M
Series A
$27M
Series B
$60M
Angel/Seed (2019): $5M, investors not publicly disclosed
Series A (2021): $27M led by Vaekstfonden, Hearcore, Id Invest, byFounders, and Chr. Augustinus Fabrik
Series B (2023): $60M supported by EiFO, Atomico, and Eurazeo
Key Investors in Corti
Atomico
Atomico is a European Venture Capital firm headquartered in London, with offices in Paris, Berlin and Stockholm. Its founder and CEO is Niklas Zennström, a serial entrepreneur who co-founded Skype and Kazaa.
Eurazeo
Headquartered in Paris and founded in 1969, Eurazeo is a leading global investment company with considerable private equity, venture capital, real estate, and private debt, Eurazeo acsupports companies of all sizes in their development by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
byFounders
byFounders VC is a community-powered early-stage venture fund that invests in globally ambitious teams connected to the Nordic and Baltic countries. The firm leverages a unique Collective of founders and operators to provide operational expertise and a global network to its portfolio companies.
What's next for Corti?
The substantial enterprise-level funding, particularly the recent Series B round, signals a critical phase of scaling and market expansion for Corti. This strategic investment will likely fuel further development of its AI capabilities, enhance its go-to-market strategy, and potentially broaden its reach into new healthcare systems and international markets. The company's focus on improving clinical efficiency and patient outcomes through AI positions it for continued growth and impact in the health-tech landscape.
See full Corti company page
